Activity value 72england Buyer&Supplier,Last transaction date:
2025-08-23Address: rkonnect ltd unit 20 oliver busines s park oliver road, park royal lond,on nw10 7jb united kingdom
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for silicon pharma from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 12 transactions, with a transaction quantity of 40 and a transaction weight of 0.
YearTransactionsQuantityWeight
2024171270
202512400
Bill of lading data
<
1/15
>
Trade date
2025/06/13
B/L No.
3200664
Suppliers
silicon pharma
Buyers
veeda clinical research ltd.
Product description
CONCOMITANT MEDICATION (C): DEXAMETHASONE TABLETS-(7X28=196TABLETS)-(FOC/NCV)- FOR TEST OR ANALYSIS PURPOSESCONCOMITANT MEDICATION (C) DEXAMETHASONE TABLETS-(7X28196 TA
Expand
Trade date
2025/06/13
B/L No.
5818416
Suppliers
silicon pharma
Buyers
veeda clinical research ltd.
POLs
——
PODs
ahmedabad air
Supply area
England
Purchas area
India
Weight
——
Amount
14.2488
Hs code
30049099
Product tags
cord,lysi,duct,mg tablet,hydrocortisone,abs,ce pro
Product description
TOPAMX SPRINKLE (TOPIRAMATE) 50 MG HARD CAPSULES-(5X60=300 CAPS)-(FOC/NCV)-FOR TEST AND ANALYSIS PURPOSES ONLYTOPAMX SPRINKLE (TOPIRAMATE) 50 MG HARD CAPSULES-(5X60300 CA
Expand
Trade date
2025/05/13
B/L No.
2035169
Suppliers
silicon pharma
Buyers
cliantha research ltd.
Product description
(TOPAMAXSPRINKLE) TOPIRAMATE HARD CAPSULES (50 MG) (TL NO: TL/AZ/23/002157) (QTY: 5X60=300CAP) FOR R&D PURPOSE NOT FOR S(TOPAMAXSPRINKLE) TOPIRAMATE HARD CAPSULES (50 MG) (TL NO: T
Expand
Product description
MEDICAMENTS CONSISTING OF MIXED OR UNMIXED PRODUCTS FOR THERAPEUTIC OR PROPHYLACTIC PURPOSES, PUT UP IN MEASURED DOSES INCL. THOSE FOR TRANSDERMAL ADMINISTRATION OR IN FORMS OR PACKINGS FOR RETAIL SALE (EXCL. CONTAINING ANTIBIOTICS, HORMONES OR STEROIDS USED AS HORMONES, ALKALOIDS, PROVITAMINS, VITAMINS, THEIR DERIVATIVES, ANTIMALARIAL ACTIVE PRINCIPLES AND BLINDED CLINICAL TRIAL KITS)
Expand
silicon pharma is england Buyer&Supplier,
and primarily engages in the import and export business of products such as ale,tablet,sprinkle.
According to the 52wmb.com global trade database, as of 2025-08-23, the company has completed 63 international trades,
with its main trading regions covering india etc.
The core products include HS30049099,HS30049000 etc,
and its main trading partners are zydus lifesciences ltd.,lyrus life sciences pvt ltd.,lambda therapeutic research ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on silicon pharma is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.